Article provided by: Dr. Joel Kahn, MDHe is a clinical professor at Wayne State University School of Medicine, a world-class cardiologist, best-selling author, lecturer, and a leading authority on plant-based nutrition and holistic care.
was there promising data For more than 30 years, studies have shown that atherosclerosis in the coronary and carotid arteries can be reversed to some extent by lifestyle measures centered on a plant-based diet.
“New Kid on the Block” is a nutritional supplement that combines green seaweed. A small study was recently published, which I would like to introduce here. Hopefully, larger trials will follow.
study
One of the authors reveals that she is a member of the scientific advisory board of a company that produces seaweed products. The authors report on six patients with atherosclerotic plaques in the carotid arteries. This condition poses a risk of acute ischemic stroke and indicates that atherosclerosis may be occurring elsewhere in the vasculature. The plaque was revealed by routine ultrasound measurement of carotid intima-medial thickness (CIMT), defined as the distance between the lumen-intima and media-adventitia interfaces.
Six patients followed an integrated regimen that successfully managed pre-existing cardiovascular symptoms and risk factors while controlling various biomarkers. However, they continued to show carotid plaque with no improvement. New nutritional supplements targeting endothelial glycocalyx regeneration have been added to personalized intervention programs. This supplement contains a proprietary extract of rhamnan sulfate from the green seaweed Monostroma nitidum. Six participants took the supplement daily and had their plaque burden measured six months later using the same CIMT technology.
In all cases, total plaque volume decreased, with an average reduction of 5.55 mm in 6 patients. This is statistically significant. A significant decrease in maximum carotid plaque thickness was also observed at the end of 6 months.
conclusion
This study shows that rhamnan sulfate from Monostroma nitidum green seaweed may provide a safe and effective intervention to reduce atherosclerotic plaques and may be an adjunct therapy for the prevention and treatment of cardiovascular diseases. This suggests that it should be evaluated as
Further research will be required. Accurate measurement of plaque burden with carotid IMT ultrasound and coronary CT angiography with AI interpretation allows each patient to assess the effectiveness of this and other products. If proven, it would be great to add more drugs to our lifestyle and medicine regimens that have been shown to promote atherosclerosis reversal.
